Brief: Shop Apotheke Europe Q1 Sales Growth

Galenica AG

02/05/2023 05:49

May 2 (Reuters) - SHOP APOTHEKE EUROPE NV  SAEG.DE :
    * STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER
PART
OF FULL-YEAR GUIDANCE.
    * NON-RX SALES GROWTH 23%; OUTPACING FULL-YEAR GUIDANCE OF
10 TO
20%.
    * ADJUSTED. EBITDA MARGIN 2.4%, 3.8 PP BETTER THAN Q1 2022;
UPPER
PART OF FULL-YEAR GUIDANCE OF 0.5 TO 2.5%.
    * COMFORTABLY ON TRACK FOR FULL-YEAR GUIDANCE IN ALL ITS
ELEMENTS;
NON-RX SALES GROWTH, ADJUSTED. EBITDA MARGIN AND FREE CASH FLOW.
    * CONTINUATION OF HIGH CUSTOMER SATISFACTION; NET PROMOTER
SCORE
ABOVE 70
    * CONFIRMS GUIDANCE GIVEN ON 7 MARCH
    * STRATEGIC PARTNERSHIP WITH GALENICA FOR SWISS MARKET
E-PHARMACY
LEADERSHIP

Source text for Eikon:  ID:nEQ1cl1xja 
Further company coverage:  SAEG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))